The Europe healthcare analytics market is projected to reach USD 50.91 billion by 2030 from USD 17.47 billion in 2025, at a CAGR of 23.9% during the forecast period. The Europe healthcare analytics market is growing because healthcare systems are increasingly adopting analytics to support value-based healthcare delivery, healthcare system planning, and cross-border collaborations.
Europe has emphasized a significant focus on adopting digital healthcare projects. Simultaneously, the establishment of the European Health Data Space, focusing on providing a framework for GDPR-compliant data governance, has improved data sharing mechanisms. These factors, combined, have made it simpler for analytics solution implementation in healthcare systems for these nations by enhancing healthcare data standardization and interconnectivity. Budget limitations and a lack of skilled workers in the healthcare field have led to more demand for predictive and operational analytics solutions in European countries. These analytical solutions assist in managing capacities and eliminating geographical disparities in the delivery of care. They also assist in better reimbursement outcomes in these countries. With the increasing use of EHR systems, e-prescriptions, cloud technology, and AI-powered solutions in these countries, healthcare systems in Europe are becoming increasingly interconnected, making analytics an indispensable tool in this context.
The Europe healthcare analytics market is being propelled by rapid digitalization, national EHR and population-health programs, and stricter GDPR/EHDS-driven data governance, which together are increasing demand for predictive analytics, AI-enabled clinical decision support, and cloud-native population-health platforms.
To know about the assumptions considered for the study download the pdf brochure
Leading companies in the Europe healthcare analytics market include Merative (US), SAS Institute Inc. (US), Optum, Inc. (US), Oracle (US), Veradigm LLC (US), ExlService Holdings, Inc. (US), CitiusTech Inc. (India), Health Catalyst (US), CVS Health (US), McKesson Corporation (US). To strengthen their presence and capture a larger share of the Europe healthcare analytics market, these companies are adopting both organic and inorganic growth strategies, including partnerships, product launches, acquisitions, platform expansions, interoperability initiatives, and collaborations with healthcare providers and government agencies.
In November 2025, Siemens Healthineers (Germany) outlined a new strategic focus on healthcare AI and digital innovation, with plans to accelerate cloud and AI capabilities that support remote diagnostics and telehealth integration as part of broader personalized care delivery efforts across global markets, including Europe.
In February 2025, Koninklijke Philips N.V. (Netherlands) expanded its cloud-based radiology informatics services (Philips HealthSuite Imaging) across Europe, enabling secure, cloud-accessible diagnostic workflows and remote access to imaging and AI-enabled clinical tools that support telemedicine and virtual care delivery across multiple EU countries.
Optum (US)
Optum is a leading global healthcare analytics, population health intelligence, and focused decision support solutions provider with an increasing foothold in Europe. The company operates in three main segments: clinical analytics, population health & risk stratification solutions, and enterprise performance optimization, serving hospitals, healthcare payers, public health authorities, and life science companies. Optum offers integrated claims, EHR, treatment, and real-world healthcare analytical solutions in Europe to improve European healthcare systems with enhanced quality and financial viability.
The European expansion strategy of Optum centers on developing AI-powered predictive analytics capabilities, scaling cloud-based health intelligence platforms, and forging relationships with European national health systems and universities. During 2024 and 2025, Optum continued to enhance its risk adjustment and population health analytics offerings in both the UK and Ireland. Additionally, they enhanced their collaborations in data science and health economics with European pharmaceutical companies to support real-world evidence generation. With a dedicated presence in Europe through Optum UK, they have successfully enabled healthcare digital transformation in Europe.
Oracle (US)
Oracle is a leading provider of cloud-based healthcare data platforms, analytics solutions, and population-level intelligence tools across Europe. Leveraging Oracle Cloud Infrastructure (OCI), the company offers a comprehensive suite of EHR-integrated analytics, clinical data warehousing, AI-driven predictive modeling, and public health intelligence tools used by hospitals, research institutes, and government health agencies. Following its acquisition of Cerner, Oracle strengthened its footprint in Europe, accelerating integration of advanced analytics into Cerner Millennium deployments across the UK, Ireland, Spain, and the Nordics. In 2025, Oracle expanded its cloud-based healthcare analytics and data-interoperability initiatives across multiple European health systems, supporting large-scale transitions from on-premise infrastructure to secure OCI-based platforms. The company also enhanced Cerner’s European analytics capabilities by integrating AI-driven workflow optimization, clinical risk prediction, and population-health dashboards, enabling health providers to improve care quality, reduce administrative workload, and advance national digital-health strategies. Oracle’s European operations, including R&D hubs, cloud regions, and Cerner installations, position the company as a central contributor to Europe’s healthcare data modernization and analytics transformation.
Merative (US)
Merative, formerly IBM Watson Health, is a global healthcare data, analytics, and enterprise intelligence provider with a strong and expanding presence in Europe. The company delivers advanced solutions across clinical analytics, real-world evidence generation, imaging analytics, and population health management, serving hospitals, life science companies, government agencies, and research networks. Its flagship platforms, including Merge Imaging, MarketScan, Micromedex, and Clinical Development, are widely used for clinical decision support, medical imaging management, and RWE insights across European healthcare ecosystems. In 2024–2025, Merative strengthened its European position by expanding partnerships with leading hospitals and research institutions to support AI-enhanced imaging analytics, drug-safety studies, and evidence-generation programs. The company advanced the deployment of its MarketScan Europe datasets in collaboration with European life-science companies, enabling deeper analysis of treatment patterns, outcomes, and healthcare utilization. Merative also enhanced its clinical decision-support footprint across the UK, Germany, and the Netherlands by modernizing Micromedex access models and integrating evidence-based recommendations into hospital information systems. Through regional offices, EU-compliant data infrastructure, and strong collaborations with public and private stakeholders, Merative continues to play a major role in accelerating data-driven transformation in the Europe healthcare analytics market.
Market Ranking
The Europe healthcare analytics market is moderately fragmented but rapidly evolving, with major players such as Oracle, Optum, Merative, IQVIA, Koninklijke Philips, and Siemens Healthineers leading the region through comprehensive suites of clinical analytics, population-health management tools, cloud-based data platforms, and AI-driven decision-support systems.
These companies leverage strong European footprints, including long-standing partnerships with national health systems, to support EHR integration, predictive modeling, care coordination analytics, and large-scale digital health transformation programs. Specialized analytics providers, including SOPHiA GENETICS, BC Platforms, CitiusTech, Wipro, Veradigm, and MedeAnalytics, further strengthen the competitive environment by offering advanced genomic analytics, interoperable data platforms, real-world evidence solutions, and enterprise performance analytics tailored to hospitals, payers, and life-science organizations across Europe. Emerging innovators such as Savana, Datavant, and AI-first health-tech companies are intensifying competition with breakthroughs in federated learning, clinical-NLP models, privacy-preserving data linkage, and hospital intelligence platforms designed for EU regulatory compliance (GDPR, MDR, EHDS). As European healthcare systems accelerate the adoption of digital health strategies, value-based care initiatives, and interoperable data infrastructures, vendors are increasingly differentiating themselves through cloud-native data platforms, AI-enabled predictive analytics, real-world evidence generation, and population-level insights. The growing demand for clinical efficiency, chronic-disease management, and national-scale digital transformation continues to shape a competitive yet opportunity-rich analytics landscape across Europe’s hospitals, research institutions, and public-health agencies.
Related Reports:
Europe Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Population Health), End User (Payer, Hospital, ASC) Market Size, Opportunities, Trends - Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE